HRP970161B1 - Fused imidazole derivatives as multidrug resistance modulators - Google Patents

Fused imidazole derivatives as multidrug resistance modulators

Info

Publication number
HRP970161B1
HRP970161B1 HR970161A HRP970161A HRP970161B1 HR P970161 B1 HRP970161 B1 HR P970161B1 HR 970161 A HR970161 A HR 970161A HR P970161 A HRP970161 A HR P970161A HR P970161 B1 HRP970161 B1 HR P970161B1
Authority
HR
Croatia
Prior art keywords
multidrug resistance
imidazole derivatives
fused imidazole
resistance modulators
modulators
Prior art date
Application number
HR970161A
Other languages
English (en)
Inventor
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Francois Maria Sommen
Dominique Louis Nesto Surleaux
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HRP970161A2 publication Critical patent/HRP970161A2/xx
Publication of HRP970161B1 publication Critical patent/HRP970161B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR970161A 1996-03-19 1997-03-19 Fused imidazole derivatives as multidrug resistance modulators HRP970161B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200755 1996-03-19

Publications (2)

Publication Number Publication Date
HRP970161A2 HRP970161A2 (en) 1998-04-30
HRP970161B1 true HRP970161B1 (en) 2002-06-30

Family

ID=8223797

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970161A HRP970161B1 (en) 1996-03-19 1997-03-19 Fused imidazole derivatives as multidrug resistance modulators

Country Status (30)

Country Link
US (3) US6218381B1 (fr)
EP (1) EP0888352B1 (fr)
JP (3) JP3630434B2 (fr)
KR (2) KR100330698B1 (fr)
CN (1) CN1083453C (fr)
AR (1) AR006271A1 (fr)
AT (1) ATE241626T1 (fr)
BG (1) BG62734B1 (fr)
BR (1) BR9708140A (fr)
CA (1) CA2237594C (fr)
CZ (1) CZ294060B6 (fr)
DE (1) DE69722389T2 (fr)
EA (1) EA001004B1 (fr)
EE (1) EE03773B1 (fr)
ES (1) ES2200159T3 (fr)
HK (1) HK1015769A1 (fr)
HR (1) HRP970161B1 (fr)
HU (1) HU224528B1 (fr)
ID (1) ID16375A (fr)
IL (1) IL124572A (fr)
MX (1) MX9804426A (fr)
MY (1) MY118282A (fr)
NO (1) NO310659B1 (fr)
NZ (1) NZ330466A (fr)
PL (1) PL193444B1 (fr)
SK (1) SK284434B6 (fr)
TR (1) TR199801191T2 (fr)
TW (1) TW527186B (fr)
WO (1) WO1997034897A1 (fr)
ZA (1) ZA972351B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013871A2 (fr) * 1997-09-18 1999-03-25 Janssen Pharmaceutica N.V. Derives d'imidazole fusionnes aux fins de l'amelioration de la biodisponibilite d'agents pharmaceutiques
IL138767A0 (en) * 1998-04-01 2001-10-31 Rtp Pharma Inc Anticancer compositions
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
WO2002100862A2 (fr) 2001-06-12 2002-12-19 Janssen Pharmaceutica N.V. Nouveaux derives d'imidazole tetracycliques substitues, procedes de preparation de ceux-ci, compositions pharmaceutiques les contenant et leur utilisation comme medicament
MXPA04004867A (es) * 2001-11-23 2004-07-30 Janssen Pharmaceutica Nv El uso de antihistaminicos para la reduccion aguda de presion intracraneal elevada.
GB0301736D0 (en) * 2003-01-24 2003-02-26 Xenova Ltd Pharmaceutical compounds
JP6400672B2 (ja) * 2013-03-25 2018-10-03 クリスタル ファーマ エセ．ア．ウ． アルカフタジンの製造方法
CN103408549B (zh) * 2013-06-14 2016-01-20 苏州汇和药业有限公司 一种阿卡他定中间体的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4153719A (en) * 1977-09-06 1979-05-08 Sterling Drug Inc. Aromatic diketones
JPS56125326A (en) * 1980-03-07 1981-10-01 Asahi Kagaku Kogyo Kk Preparation of chlorinated phenoxytoluenes in high selectivity
US4567184A (en) 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4778931A (en) 1982-12-01 1988-10-18 Usv Pharmaceutical Corporation Certain [3-(1-hydroxy hexyl-tetrahydro)naphthalenes], the corresponding naphthalenes having anti-inflammatory and anti-allergic activity
US4794188A (en) 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4588722A (en) 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
JPS61151176A (ja) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
AU7100887A (en) * 1986-04-07 1987-10-08 Sumitomo Chemical Company, Limited Halogenated aromatic ethers and alcohol and aldehyde intermediates
JPS6475441A (en) * 1987-09-16 1989-03-22 Sumitomo Chemical Co Production of optically active ether compound
JPH01254680A (ja) * 1988-04-01 1989-10-11 Sumitomo Chem Co Ltd 複素環化合物、その製造法およびそれを有効成分とする殺菌剤
JPH089616B2 (ja) * 1990-10-10 1996-01-31 シェリング・コーポレーション 置換されたイミダゾベンズアゼピン類およびイミダゾピリドアゼピン類
IL101851A (en) 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
ES2135463T3 (es) 1992-02-06 1999-11-01 Merrell Pharma Inc Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.
RU2134269C1 (ru) 1992-12-04 1999-08-10 Жансен Фармасетика Н.В. Производные имидазо/1,2а/тиено/2,3-d/азепинов, способ их получения, промежуточные для их получения, фармацевтическая композиция и способ их получения
CA2155759A1 (fr) * 1993-03-29 1994-10-13 Bernd Janssen Derives de 1-amino-3-phenoxypropane, agents de modulation pour la resistance a plusieurs medicaments
CN1042228C (zh) 1993-07-13 1999-02-24 詹森药业有限公司 抗过敏咪唑并吖庚因
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
FR2731708B1 (fr) 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Also Published As

Publication number Publication date
AU709683B2 (en) 1999-09-02
BG62734B1 (bg) 2000-06-30
CA2237594A1 (fr) 1997-09-25
PL327985A1 (en) 1999-01-04
HK1015769A1 (en) 1999-10-22
IL124572A (en) 2002-03-10
MX9804426A (es) 1998-09-30
AR006271A1 (es) 1999-08-11
HUP9900415A2 (hu) 1999-05-28
NO310659B1 (no) 2001-08-06
SK284434B6 (sk) 2005-04-01
KR100330698B1 (ko) 2002-10-31
NZ330466A (en) 1999-03-29
SK66298A3 (en) 1999-06-11
HRP970161A2 (en) 1998-04-30
TR199801191T2 (xx) 1998-10-21
AU2026997A (en) 1997-10-10
NO982124D0 (no) 1998-05-11
JP3630434B2 (ja) 2005-03-16
KR100349500B1 (ko) 2002-08-21
WO1997034897A1 (fr) 1997-09-25
NO982124L (no) 1998-09-18
JP2002012594A (ja) 2002-01-15
US6476018B1 (en) 2002-11-05
US6218381B1 (en) 2001-04-17
DE69722389D1 (de) 2003-07-03
IL124572A0 (en) 1998-12-06
ID16375A (id) 1997-09-25
US20030087895A1 (en) 2003-05-08
EP0888352A1 (fr) 1999-01-07
CA2237594C (fr) 2006-05-30
BG102459A (en) 1999-06-30
EP0888352B1 (fr) 2003-05-28
JP2000505477A (ja) 2000-05-09
EE03773B1 (et) 2002-06-17
ZA972351B (en) 1998-09-18
JP4251447B2 (ja) 2009-04-08
KR20000064358A (ko) 2000-11-06
DE69722389T2 (de) 2009-09-24
HU224528B1 (hu) 2005-10-28
ATE241626T1 (de) 2003-06-15
JP4205319B2 (ja) 2009-01-07
CZ294060B6 (cs) 2004-09-15
CN1083453C (zh) 2002-04-24
CZ152998A3 (cs) 1999-02-17
EA001004B1 (ru) 2000-08-28
MY118282A (en) 2004-09-30
BR9708140A (pt) 1999-07-27
ES2200159T3 (es) 2004-03-01
EE9800281A (et) 1999-02-15
PL193444B1 (pl) 2007-02-28
HUP9900415A3 (en) 2001-11-28
EA199800586A1 (ru) 1998-12-24
JP2004067701A (ja) 2004-03-04
TW527186B (en) 2003-04-11
CN1211985A (zh) 1999-03-24

Similar Documents

Publication Publication Date Title
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
GB9718913D0 (en) Substituted oxindole derivatives
GB9602294D0 (en) Heterocyclic compounds
EP0999835A4 (fr) Derives d'imidazole utilises comme modulateurs de la mdr
GB9617305D0 (en) Heterocyclic compounds
AUPO284396A0 (en) Benzodiazepine derivatives
GB2345910B (en) Photochromic compounds
AUPN980796A0 (en) Improved reservoir components
HRP970161B1 (en) Fused imidazole derivatives as multidrug resistance modulators
AU2488897A (en) Heterocyclic N-acetonylbenzamides
GB9716101D0 (en) Fused heterocyclic compounds
AU2991397A (en) Heterocyclic compounds
ZA98879B (en) Omega-cycloalkyl-prostaglandin e2 derivatives
AU3203297A (en) Heterocyclic compounds
AU2738397A (en) Heterocyclic compounds
AU2679497A (en) Heterocyclic compounds
AU2628397A (en) Improved reservoir components
ZA975175B (en) Novel photochromic heterocyclic fused indenonaph-thopyrans
AU5781498A (en) Tricyclic heterocyclic compounds
AU5600496A (en) Substituted imidazoles as modulators of multi-drug resistance
AUPN900296A0 (en) Heterocyclic compounds
GB9624565D0 (en) Multi purpose eyewear
GB9617306D0 (en) Heterocyclic compounds
GB9625458D0 (en) Heterocyclic compounds
GB9614756D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090316

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20100320